Chief Business Officer
Taylor Boyd was appointed Chief Business Officer at Avalo Therapeutics in October 2025, bringing nearly 15 years of experience in biotech business development, corporate finance, and investment banking. Most recently, he served as Executive Vice President & Chief Business Officer at Abzena, leading